Last reviewed · How we verify

NCT06233604

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty

Recruiting now Phase 4 Last updated 29 April 2024
What this trial tests

Phase 4 trial testing 0.9%sodium chloride in Hip Osteoarthritis in 30 participants. Currently enrolling.

Timeline
10 April 2024
Primary endpoint
30 March 2025
30 May 2025

Quick facts

Lead sponsorPoznan University of Medical Sciences
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date10 April 2024
Primary completion30 March 2025
Estimated completion30 May 2025
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Poznan University of Medical Sciences

Who can join

Adults 18 to 100, any sex, with Hip Osteoarthritis or Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for hip arthroplasty

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of 0.9%sodium chloride

Trials testing the same drug.

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

Other Poznan University of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06233604.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing